Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Why Hympavzi Secured English Funding For Hemophilia B But Not Hemophilia A
May 27 2025
•
By
Neena Brizmohun
England’s NICE has been assessing whether Hympavzi is cost effective
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Health Technology Assessment
More from Geography